Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-30

Clinical Trial Update: The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on astaxanthin as add-on therapy for painful diabetic neuropathy, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Astaxanthin

Snippet

Sponsor: Duta Wacana Christian University | Conditions: Painful Diabetic Neuropathy | Phase 2, Phase 3 | Status: UNKNOWN